Skip to main content
White paper

Commercial drug trends: 2024 release

24 July 2024

Pharmacy benefit costs continue to rise year over year, driven by a variety of factors including novel treatments, consumer demand, and federal legislation. This report provides insights into pharmacy cost and utilization trends based on our analysis of the Milliman Consolidated Health Cost Guidelines Sources Database. In this report you’ll find insights on emerging pharmacy trends, including:

  • Weight-loss drugs
  • Antidiabetics
  • Biosimilars
  • Copay assistance
  • Attention-deficit/hyperactivity disorder (ADHD)

About the Author(s)

Andrew Dressler

Niharika Tarimela

Jason Mui

We’re here to help